Comparing intranasal retatrutide to other nasal peptides Intranasal retatrutide is not the first peptide to be explored through nasal delivery
Research in humans is a bit less impressive Clinical trials in humans A 1981 double-blind study found that chronic insomniac patients found that subjects slept 59% more, shorter sleep latency, and higher sleep efficiency (Schneider 1981) A 1987 double-blind study did not find any statistically significant changes in sleep structure as measured by REM sleep, NREM sleep, or total sleep time (Debellis 1987) A 1992 double-blind study in 14 chronic insomnia patients found higher sleep efficiency and subjectively estimated tiredness decreased to similar levels of healthy subjects in 7 nights of injections (Schneider 1992) There are some limitations to these studies however
Disclaimer: Retatrutide is not currently FDA approved and is not yet available by prescription
Others want fat loss with muscle preservation
Medicaid, VA, TRICARE, and DoD beneficiaries are excluded from Lillys savings cards
Runners and returning athletes who skip rehab and rely on the stack alone see slower functional recovery even when pain resolves quickly